Trypsin >0.5 µKatal/mg Source : Bovine pancreas

Added to your cart

Trypsin >0.5 µKatal/mg Source : Bovine pancreas

Cart subtotal: £0.00

View cart (0) Checkout

#SKU 201553BBI

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Trypsin is widely distributed in animals and in some bacteria and is classed as a serine protease. Trypsin is present in the pancreas and pancreatic juice in vertebrates. Trypsinogen, secreted into the duodenum as a pro-enzyme, is activated by Enterokinase secreted by the duodenal mucosa. Trypsin is obtained by activation of its inactive precursor (Trypsinogen) by Enterokinase and by Trypsin itself. Calcium stimulates the autoactivation of Trypsinogen. Trypsin has a high degree of substrate specificity as it catalyses the hydrolysis of peptide bonds on the carboxyl terminus of positively charged amino acids such as Lysine and Arginine. Trypsin has a weak action on native proteins and will not hydrolyze serum globulins, haemoglobin, ovalbumin or collagen.


More information



  • Shipping Information
  • Ambient Shipping
  • Associated Activity
  • Loss on Drying (4 hours @ 60 0C): ≤5%
  • Lead Time
  • 14 weeks to 6 months raw material depending
  • Storage
  • -20
  • Shelf Life
  • Retest date 48 months
  • Source
  • Bovine pancreas
  • Activity
  • ≥2500 U/mg material
  • EC Number
  • Form
  • White to off-white, salt-free, freeze-dried powder

Technical Documents

Product Specification (75.55KB)

Product Information (373.29KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox